Navigation Links
Biofuels Technology Leader Qteros Names Industry Veteran John McCarthy President and Chief Executive Officer
Date:1/13/2010

18-year track record of success building leading life science and bio-based chemical companies, including cellulosic ethanol pioneer Verenium Corporation

MARLBOROUGH, Mass., Jan. 13 /PRNewswire-USNewswire/ --  Qteros, Inc., a leading developer of second-generation technology solutions for the biofuels industry based on its unique Q Microbe(TM) platform, announced today that John McCarthy has joined the company as President and Chief Executive Officer  to accelerate the company's technology and commercial initiatives in the worldwide cellulosic ethanol marketplace.

(Logo: http://www.newscom.com/cgi-bin/prnh/20100113/DC37180LOGO-b)

(Photo: http://www.newscom.com/cgi-bin/prnh/20100113/DC37180-a)

Mr. McCarthy's 18-year experience includes managing the transformational growth of numerous leading life science and bio-based chemical companies into high-value commercial entities. He has raised over $1 billion of capital in the private and public markets, and developed and executed numerous complex and large-scale strategic corporate partnerships.  

Mr. McCarthy joins Qteros from Microbia, Inc., where he served as Chief Business Officer of this developer of unique bio-based specialty chemicals for large-scale industrial applications. Prior to Microbia, Mr. McCarthy was Executive Vice President for publicly-traded Verenium Corporation, a pioneering leader in the development and commercialization of cellulosic ethanol and specialty enzymes.  At Verenium, McCarthy served as the chief architect of the company's growth from a small privately-held business into a publicly-traded leader in the industry through the successful merger and integration of Celunol and Diversa and the subsequent creation and execution of the industry's precedent-setting strategic corporate partnership with BP plc.

"We are thrilled to have John join us at this important stage of Qteros' development to lead and accelerate our technical, commercial and organizational growth plans," stated Steve Goldby, Qteros board member and Partner at Venrock Associates. "John's experience building pioneering companies in the biofuels industry such as Verenium, together with his proven track record of developing and managing complex strategic corporate partnerships, make him uniquely qualified to lead and position Qteros for significant growth."

"I am very pleased and excited to be joining Qteros at this critical stage of its development, and look forward to accelerating our technical and commercial plans as we focus on making our Q-Microbe™ platform a cellulosic ethanol industry standard," stated McCarthy.

"The broad alternative energy industry represents one of the most important and high-growth opportunities for this generation," McCarthy added. "I look forward to positioning Qteros and its partners as a leading technology solution to support the multi-billion gallon per year U.S. mandate and worldwide requirement for cellulosic ethanol production."

Mr. McCarthy's prior experience includes senior executive positions at Xanthus Pharmaceuticals, Synta Pharmaceuticals, Exact Sciences, Concentra Managed Care, and Morgan Stanley. Mr. McCarthy graduated with high honors from Lehigh University and received his MBA from the Harvard Business School.

About Qteros, Inc.

Qteros is a venture capital-backed company committed to delivering innovative process technologies for clean transportation fuels that reduce greenhouse gas emissions at a price competitive with gasoline. The company is currently in the process of scaling up a unique microbial solution for the highly efficient and cost effective conversion of non-food plants and waste into clean transportation fuel. The company's patented Q Microbe™ system converts a wide array of cellulosic biomass directly into ethanol in a single step, consolidating enzymatic hydrolysis and fermentation, largely eliminating costly enzymes and associated pretreatments, and greatly simplifying the entire production process. Qteros' scientists and business team are dedicated to producing liquid fuels to achieve a sustainable solution to the world's growing energy needs. Qteros has been funded by some of the leading investors in the alternative energy industry, including among others, Venrock Associates, Battery Ventures, BP Technology Ventures, Soros Fund Management LLC and Valero Energy Corporation.  For more information, visit www.Qteros.com.

SOURCE Qteros, Inc.

RELATED LINKS
http://www.qteros.com/

'/>"/>

SOURCE Qteros, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
2. N.C. Takes Biofuels Leadership, Establishes New Endeavor With $5 Million State Appropriation
3. Healthcare Announced That an Overwhelming Majority of its Shareholders Approved the NexGen Biofuels Transaction
4. Healthcare Technologies Ltd. Announces the Change of its Name to "NexGen Biofuels Ltd"
5. NexGen Biofuels Ltd. (Nasdaq: NXGN) Announces Receipt of Nasdaq Delisting Determination
6. NexGen Biofuels Ltd. Announces Trading on OTC Bulletin Board
7. Monsanto Company and Mendel Biotechnology Announce Cellulosic Biofuels Collaboration
8. Performance Plants Establishes U.S. Biofuels Facility
9. NexGen Biofuels Ltd. Announces Plans to Replace its CFO With Local CFO
10. New Generation Biofuels Set to Join Russell Microcap Index
11. DOE JGI Director Eddy Rubin highlights the genomics of plant-based biofuels in the journal Nature
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... N.C. (PRWEB) , ... June 27, 2016 , ... ... commercial operations for Amgen, will join the faculty of the University of ... as adjunct professor of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus ...
(Date:6/27/2016)... BOSTON , June 27, 2016   Ginkgo ... biology to industrial engineering, was today awarded as ... a selection of the world,s most innovative companies. ... at scale for the real world in the ... organism engineers work directly with customers including Fortune ...
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/24/2016)... ... , ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical ... mesothelioma. Their findings are the subject of a new article on the Surviving Mesothelioma ... in the blood, lung fluid or tissue of mesothelioma patients that can help point ...
Breaking Biology Technology:
(Date:6/27/2016)... 27, 2016 Research and Markets has announced ... report to their offering. ... to grow at a CAGR of 12.28% during the ... on an in-depth market analysis with inputs from industry experts. The ... coming years. The report also includes a discussion of the key ...
(Date:6/22/2016)... 2016  The American College of Medical Genetics and Genomics ... as one of the fastest-growing trade shows during the ... Bellagio in Las Vegas . ... growth in each of the following categories: net square feet ... of attendees. The 2015 ACMG Annual Meeting was ranked 23 ...
(Date:6/22/2016)... 2016   Acuant , the leading ... has partnered with RightCrowd ® to ... Management, Self-Service Kiosks and Continuous Workforce Assurance. ... functional enhancements to existing physical access control ... with an automated ID verification and authentication ...
Breaking Biology News(10 mins):